China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.26 +0.02 (+0.89%)
As of: Sep 9, 2026 · 12:55 PM EDT

China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2020)

China SXT Pharmaceuticals (SXTC) posted Current Deferred Tax Assets of $50000.0 for Q1 2020.

Analysis

China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2020) Analysis & Trends

China SXT Pharmaceuticals has reported Current Deferred Tax Assets for 1 years, with the latest figure at $50000.0 in Q1 2020.

  • On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $50000.0 in Q1 2020; TTM through Mar 2020 was $50000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $50000.0, changed N/A from the prior year.
  • Current Deferred Tax Assets was $50000.0 for Q1 2020 at China SXT Pharmaceuticals.
  • The five-year high for Current Deferred Tax Assets was $50000.0 in Q1 2020, with the low at $50000.0 in Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn
10 China SXT Pharmaceuticals 19,200.96 -28.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 50,000.00